Chi-Kin Chow

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A

Ling Liu, Kristine Kikly, Jirong Lu et al. · Journal of Inflammation Research · 2016 · 204 citations · Full text

Clinical Immunology, Immunology, Immune Regulation +16

Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure

Chi-Kin Chow, Barrett W. Allan, Qing Chai et al. · Molecular Pharmaceutics · 2016 · 68 citations

High Concentrations, Crystal Structure, High Concentration +17

FcRn Affinity-Pharmacokinetic Relationship of Five Human IgG4 Antibodies Engineered for Improved In Vitro FcRn Binding Properties in Cynomolgus Monkeys

Amita Datta‐Mannan, Chi-Kin Chow, Craig D. Dickinson et al. · Drug Metabolism and Disposition · 2012 · 56 citations

Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease

Robert J. Benschop, Chi-Kin Chow, Yu Tian et al. · mAbs · 2019 · 49 citations · Full text

Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (<scp>MET</scp>)

Aaron M. Gruver, Ling Liu, Peter Vaillancourt et al. · Histopathology · 2014 · 16 citations · Full text